Form 8-K - Current report:
SEC Accession No. 0001731122-25-000354
Filing Date
2025-03-06
Accepted
2025-03-06 16:20:03
Documents
14
Period of Report
2025-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e6404_8-k.htm   iXBRL 8-K 40526
2 EXHIBIT 10.1 e6404_ex10-1.htm EX-10.1 22736
  Complete submission text file 0001731122-25-000354.txt   244728

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE renb-20250228.xsd EX-101.SCH 3030
4 XBRL LABEL FILE renb-20250228_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE renb-20250228_pre.xml EX-101.PRE 22369
16 EXTRACTED XBRL INSTANCE DOCUMENT e6404_8-k_htm.xml XML 3686
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO INC. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38758 | Film No.: 25715541
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)